Last reviewed · How we verify
NCT04051515: HoBIDnurse
Home-based vs Intradialysis Exercise Guided by Nursing Staff
NA trial testing Intradialysis exercise training in End Stage Renal Disease on Dialysis in 70 participants. Completed in 29 November 2019.
29 November 2019
Quick facts
| Lead sponsor | Cardenal Herrera University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 9 August 2019 |
| Primary completion | 29 November 2019 |
| Estimated completion | 29 November 2019 |
| Sites | 7 locations across Belgium, Sweden, Greece, Spain |
Drugs / interventions tested
- Intradialysis exercise training
- Home-based exercise training
Conditions studied
- End Stage Renal Disease on Dialysis — all drugs for End Stage Renal Disease on Dialysis →
Sponsor
Cardenal Herrera University
Who can join
18 and older, any sex, with End Stage Renal Disease on Dialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Participants will be randomized either to home-based exercise or to intradialysis exercise guided by nurses of the renal unit. The programs will last 16 weeks. The intradialysis exercise consists of combined aerobic and resistance training exercise. The home-based exercise consists of resistance exercise and walking.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A dataset of the effects of therapeutic exercise programs on physical function in patients undergoing hemodialysis.
Perez-Dominguez B, Lopez-Brull A, Perpiña-Martinez S, Casaña J, et al · · 2023 · cited 1× · PMID 36950561 · DOI 10.1016/j.dib.2023.109048
Verify or expand the search:
- PubMed search for NCT04051515
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for End Stage Renal Disease on Dialysis
Currently open trials in the same condition.
- NCT07053462 — CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk · Phase 1, PHASE2 · recruiting
- NCT07016841 — Effects of pHA Hemoperfusion Plus Hemodialysis on Protein-Bound Uremic Toxins · recruiting
- NCT05654103 — Comparing Surgical and Endovascular Arteriovenous Fistula Creation · NA · recruiting
- NCT06483074 — Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients · Phase 2 · recruiting
- NCT06249932 — Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease · Phase 4 · recruiting
Other Cardenal Herrera University trials
Trials by the same sponsor.
- NCT07471269 — Online Pain Neuroscience Education For Fear Of Childbirth. · NA · recruiting
- NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
- NCT07499856 — Intradialytic Exercise Program Supported by Audiovisual Media Combined With Mindfulness · NA · enrolling by invitation
- NCT07275112 — Cross-cultural an Reliability and Validity Evaluation of TENDINS-A in Spain · completed
- NCT07133581 — Design and Validation of FEXO: A Playful Exercise Program for Institutionalized Frail Older Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04051515 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardenal Herrera University
- Last refreshed: 29 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04051515.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing